Posted in | News

Rinker Demerger from CSR Approved

Download PDF Copy

Apr 14 2003

The proposed demerger of Rinker Group from CSR Ltd has been approved by Australian Courts.

Both companies will be based in Sydney (Australia) and will trade on the Australian Stock Exchange (ASX).

CSR shareholders will retain their shares and will receive 1 Rinker share for each CSR share held on April 4th. Although Rinker will begin trading on the ASX as of March 31, the demerger will not formally take place until April 11th.

Rinker will consist of approximately 70% of CSR’s assets and is expected to be one of the world’s top ten heavy building materials groups in the world. With operations in Australia, USA and China they will deal in aggregates, cements, premix concrete and concrete pipe and products.

CSR will become a more diversified company dealing in sugar, aluminium and building products such as insulation, plasterboard and roof tiles.

Source:

CSR

Download PDF Copy

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback

Public Comment

Private Feedback to AZoBuild.com

Submit

What To Know About Bioengineered Construction Materials

What To Know About Bioengineered Construction Materials

This article will provide an overview of bioengineered building materials, discussing materials, products, and projects that have been made possible due to research in this area.

Reducing Embodied Carbon Through Design

Reducing Embodied Carbon Through Design

With an increase in the pressure to decarbonize the built environment and build more carbon-neutral buildings, the reduction of embodied carbon has become of great importance.

Calcium Carbonate Concrete: Building on Recycling

Calcium Carbonate Concrete: Building on Recycling

AZoBuild talks to Professors Noguchi and Maruyama about their research and development of Calcium Carbonate Concrete (CCC), a new material that has the potential to cause a sustainable revolution in the construction industry.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.